Post-Intake of S-Ethyl Cysteine and S-Methyl Cysteine Improved LPS-Induced Acute Lung Injury in Mice

Nutrients. 2016 Aug 19;8(8):507. doi: 10.3390/nu8080507.

Abstract

The effects of S-ethyl cysteine (SEC) and S-methyl cysteine (SMC) on lipopolysaccharide (LPS)-induced acute lung injury in mice were examined. Eight hours after LPS challenge, SEC or SMC was supplied in drinking water at 0.5% or 1% for 3 days. LPS increased lung myeloperoxidase activity, neutrophil counts and edema. SEC or SMC post-intake attenuated these events. SEC or SMC suppressed LPS-induced lung expression of cyclooxygenase-2, nuclear factor-κB and mitogen-activated protein kinase, and lowered the generation of tumor necrosis factor-alpha, monocyte chemoattractant protein-1 and prostaglandin E₂. LPS enhanced the expression of p47(phox), gp91(phox), Bax and cleaved caspase-3, and increased the production of reactive oxygen species in the lung. SEC or SMC post-intake reversed these alterations. These findings suggest that these agents could protect the lung through their anti-inflammatory, anti-oxidative and anti-apoptotic activities.

Keywords: LPS; S-ethyl cysteine; S-methyl cysteine; inflammation; lung.

Publication types

  • Retracted Publication

MeSH terms

  • Acute Lung Injury / chemically induced
  • Acute Lung Injury / drug therapy*
  • Animals
  • Cysteine / administration & dosage
  • Cysteine / analogs & derivatives*
  • Cysteine / pharmacology
  • Gene Expression Regulation / drug effects
  • Lipopolysaccharides / toxicity*
  • Lung / enzymology
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Peroxidase / metabolism

Substances

  • Lipopolysaccharides
  • S-methylcysteine
  • S-ethylcysteine
  • Peroxidase
  • Cysteine